Greiner Bio-One International GmbH, commonly referred to as Greiner Bio-One, is a leading player in the life sciences industry, headquartered in Austria (AT). Founded in 1868, the company has established a strong presence in key operational regions across Europe, North America, and Asia. Specialising in the development and production of innovative products for laboratory and medical applications, Greiner Bio-One is renowned for its high-quality plastic solutions, including blood collection systems, cell culture products, and diagnostic devices. With a commitment to research and development, Greiner Bio-One has achieved significant milestones, positioning itself as a trusted partner in the healthcare sector. The company’s focus on sustainability and user-friendly designs sets its offerings apart, ensuring they meet the evolving needs of laboratories and healthcare professionals worldwide.
How does Greiner Bio One's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Greiner Bio One's score of 44 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Greiner Bio One reported total carbon emissions of approximately 2,566,618,000 kg CO2e. This figure includes Scope 1 emissions of about 25,075,000 kg CO2e, Scope 2 emissions of approximately 69,647,000 kg CO2e, and significant Scope 3 emissions totalling around 2,471,896,000 kg CO2e. Over the years, Greiner Bio One has shown fluctuations in its emissions. For instance, in 2022, total emissions were about 2,847,206,000 kg CO2e, while in 2021, they were approximately 2,487,842,000 kg CO2e. The company has made strides in reducing its emissions intensity, achieving a specific emissions rate of 0.045 kg CO2e per EUR of revenue in 2023, down from 0.039 kg CO2e in 2022 and 0.06 kg CO2e in 2021. Despite these efforts, there are currently no documented reduction targets or climate pledges from Greiner Bio One, indicating a potential area for future commitment. The company operates within a global context where many organisations are increasingly focusing on sustainability and carbon neutrality, highlighting the importance of setting clear reduction goals.
Access structured emissions data, company-specific emission factors, and source documents
Add to project2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
Scope 1 | 21,134,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 136,595,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Greiner Bio One is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.